Results 221 to 230 of about 603,480 (300)

Cost-effectiveness of degarelix versus LHRH agonists in prostate cancer: a systematic review. [PDF]

Front Health Serv
Wang W, Li S, Liu W, You X, Liu Y, Wang X.   +5 more
europepmc   +1 more source

Cost Analysis Insights for Offshore CCS Hubs: A Case Study of the Santos Basin, Brazil

Greenhouse Gases: Science and Technology, EarlyView.
ABSTRACT The reuse of decommissioned offshore platforms for geological carbon storage offers a cost‐effective and technically feasible strategy to reduce greenhouse gas emissions in emerging economies. This study presents a comprehensive techno‐economic assessment of offshore carbon capture and storage (CCS) hubs in Brazil, with a focus on the Merluza ...
Norah A. Ordoñez, Mariana Ciotta, Hirdan Katarina de Medeiros Costa, Livia Koch Sposito, Daniel Alkmin   +4 more
wiley   +1 more source

New legal category of 'advanced regenerative medicine treatment' in Korea's amended regenerative medicine law: comparative lessons from Japan. [PDF]

Stem Cell Reports
Yoon J, Lee S, Kim JH.
europepmc   +1 more source

Insurance: Indian and Foreign Firms Test Positive for Growth Steroid [PDF]

, 2006
Knowledge@SMU
core  

Pharmaceutical Pricing and R&D as a Global Public Good

Health Economics, EarlyView.
ABSTRACT This paper examines the international variation in the prices of branded pharmaceuticals. We consider short‐run profits, or quasi‐rents, as representing each country's contribution toward the global public good of therapeutic information embodied in new pharmaceuticals.
H. E. Frech III, Mark V. Pauly, William S. Comanor, Joseph R. Martinez   +3 more
wiley   +1 more source

Private health insurance in Gulf Cooperation Council countries: A scoping review. [PDF]

Health Policy Open
Reka H, van Kessel R, Mossialos E, Groot W, Pavlova M.   +4 more
europepmc   +1 more source

Disparity in the Markers of Affordability Across Targeted‐ and Immune‐Therapy Drugs Used in Head and Neck Cancers

Head &Neck, EarlyView.
ABSTRACT Background The expanding use of systemic therapies for recurrent and metastatic head and neck cancer has raised major concerns regarding affordability and equitable access, particularly across countries with differing income levels and health financing structures.
Arjun Gurmeet Singh, Labani Kole, Richard Sullivan, Shwetabh Sinha, Rathan Shetty, Poonam Joshi, Sudhir Nair, Sarbani Ghosh Laskar, Kumar Prabhash, Pankaj Chaturvedi   +9 more
wiley   +1 more source

Development and validation of a concussion risk prediction model using 2023 National Health Interview Survey (NHIS) data. [PDF]

Medicine (Baltimore)
Yang S, Chen Y, Huang S, Deng Y, Zhou X, Li Y.   +5 more
europepmc   +1 more source

Trends in non-pharmacological treatment for insomnia: A nationwide study. [PDF]

PLoS One
Choi M, Lee J, Lee J, Lee S, Lee E, Shin J.   +5 more
europepmc   +1 more source